Drug · DIN 02233014
COPAXONE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since April 28, 2011; first marketed October 14, 1997.
- Drug Identification Number (DIN)
- 02233014
- Company (DIN owner)
- Teva Pharmaceutical Industries LtdPetach Tikva, Israel
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Glatiramer acetate L03AX13
- Class
- Human
- Record last updated
- June 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GLATIRAMER ACETATE | 20 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 15, 2006: NOC 8410New Drug Submission (NDS) · Manufacturer name change
- September 4, 1997: NOC 3831New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “copaxone”. A notice may cover another product or only some lots: read it to see what it covers.
- Important Safety Information on COPAXONE (glatiramer acetate) and the Risk of Anaphylactic Reactions Which May Occur at Any Time Following Initiation of TreatmentAugust 21, 2025 · Drugs · New safety information - Product safety - Adverse reaction
Other DINs named COPAXONE
- DIN 02245619 · Marketed
- DIN 02456915 · Marketed
- DIN 02512173 · Approved